SciClone Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- SciClone Pharmaceuticals's estimated annual revenue is currently $7.5M per year.
- SciClone Pharmaceuticals's estimated revenue per employee is $72,816
- SciClone Pharmaceuticals's total funding is $134M.
Employee Data
- SciClone Pharmaceuticals has 103 Employees.
- SciClone Pharmaceuticals grew their employee count by -6% last year.
SciClone Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO, SVP, Finance | Reveal Email/Phone |
2 | VP Finance/Controller | Reveal Email/Phone |
3 | Director Quality Assurance | Reveal Email/Phone |
4 | Accounting Manager | Reveal Email/Phone |
SciClone Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is SciClone Pharmaceuticals?
SciClone's strategic goal is to become the principal worldwide provider of immune system enhancers as monotherapies and as critical components of combination drug therapies for infectious diseases and cancer. Other drugs in SciClone's pipeline are intended to protect and expand this franchise and to address the protein-based disorder that causes cystic fibrosis.
keywords:N/A
$134M
Total Funding
103
Number of Employees
$7.5M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SciClone Pharmaceuticals News
2022-04-06 - Tessa Therapeutics Appoints Wilson W. Cheung as Chief Financial Officer
and served as SVP and CFO at SciClone Pharmaceuticals, Inc. where he led the sale of SciClone to a private equity firm for more than US$600...
2022-03-22 - China's Nuance Pharma in-licenses Asian rights to Bavarian ...
... who previously founded Shanghai-based Novamed Pharmaceuticals Inc., which was acquired by Sciclone Pharmaceuticals Inc. in 2011.
Other Companies in Foster City
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15.7M | 108 | N/A | N/A |
#2 | $36.6M | 111 | 6% | $145.6M |
#3 | $31.6M | 117 | 1% | N/A |
#4 | $17.4M | 120 | 7% | N/A |
#5 | $26.7M | 132 | 8% | N/A |